Current Drug Delivery
Volume 16, 10 Issues, 2019
ISSN: 1875-5704 (Online)
ISSN: 1567-2018 (Print)
This journal supports open access
ISSN: 1875-5704 (Online)
ISSN: 1567-2018 (Print)
This journal supports open access
Contents
Current Drug Delivery, Volume 14 - Number 6
Biography Open Access
Editorial Open Access
Review Article
Role of microRNAs on Blood Brain Barrier Dysfunction in Vascular Cognitive Impairment
, 14(6): 744 - 757Kensuke Toyama, Joshua Michael Spin and Philip Shih Tsao*
DOI: 10.2174/1567201813666160830124627
Role of microRNAs on Blood Brain Barrier Dysfunction in Vascular Cognitive Impairment
Review Article
Stem Cell Therapies for Intracerebral Hemorrhages
, 14(6): 758 - 765Norihito Shimamura*, Naoya Mtsuda, Kosuke Ktayama, Kiyohide Kakuta, Takeshi Katagai, Masato Naraoka and Hiroki Ohkuma
DOI: 10.2174/1567201813666160922115830
Stem Cell Therapies for Intracerebral Hemorrhages
Review Article
Osteopontin as a Potential Therapeutic Target for Ischemic Stroke
, 14(6): 766 - 772Qiquan Zhu, Xu Luo, Jie Zhang, Yun Liu, Hansheng Luo, Qin Huang, Yuan Cheng and Zongyi Xie*
DOI: 10.2174/1567201814666161116162148
Osteopontin as a Potential Therapeutic Target for Ischemic Stroke
Review Article
Pericyte: Potential Target for Hemorrhagic Stroke Prevention and Treatment
, 14(6): 773 - 784Qiang Li, Xin Liu, Huaizhen Ruan, Yujie Chen* and Hua Feng*
DOI: 10.2174/1567201813666160829103222
Pericyte: Potential Target for Hemorrhagic Stroke Prevention and Treatment
Review Article
Review: Therapeutic Targeting of HMGB1 in Stroke
, 14(6): 785 - 790Xiaodi Tian, Chenglin Liu, Zhang Shu* and Gang Chen*
DOI: 10.2174/1567201813666160808111933
Review: Therapeutic Targeting of HMGB1 in Stroke
Review Article
PD-1/PD-Ls: A New Target for Regulating Immunopathogenesis in Central Nervous System Disorders
, 14(6): 791 - 796Jie Wu, Zhengquan Yu and Gang Chen*
DOI: 10.2174/1567201814666161123152311
PD-1/PD-Ls: A New Target for Regulating Immunopathogenesis in Central Nervous System Disorders
Review Article
Sestrins: A New Kid for Stroke Treatment?
, 14(6): 797 - 806Xudan Shi, Liang Xu, Jay Malagult, Jiping Tang, Min Yan and John H. Zhang*
DOI: 10.2174/1567201814666161111125249
Sestrins: A New Kid for Stroke Treatment?
Review Article
Simultaneous Bilateral Basal Ganglia Hemorrhage
, 14(6): 807 - 815Zesong Yang, Jianjun Chen and Jun Mu*
DOI: 10.2174/1567201813666160607202811
Simultaneous Bilateral Basal Ganglia Hemorrhage
Review Article
The Role of microRNA in Ischemic and Hemorrhagic Stroke
, 14(6): 816 - 831Lipkova Jolana and Duris Kamil*
DOI: 10.2174/1567201813666160919142212
The Role of microRNA in Ischemic and Hemorrhagic Stroke
Review Article
The Updated Role of Oxidative Stress in Subarachnoid Hemorrhage
, 14(6): 832 - 842Yang Yang, Sheng Chen* and Jian-Min Zhang
DOI: 10.2174/1567201813666161025115531
The Updated Role of Oxidative Stress in Subarachnoid Hemorrhage
Research Article
Current Therapeutic Drugs Against Cerebral Vasospasm after Subarachnoid Hemorrhage: A Comprehensive Review of Basic and Clinical Studies
, 14(6): 843 - 852Shu Hasegawa, Yu Hasegawa* and Masaki Miura
DOI: 10.2174/1567201813666160808100937
Current Therapeutic Drugs Against Cerebral Vasospasm after Subarachnoid Hemorrhage: A Comprehensive Review of Basic and Clinical Studies
Research Article
Erythropoietin Treatment in Patients with Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
, 14(6): 853 - 860Xiyang Yao, Dapeng Wang, Haiying Li, Haitao Shen, Zhang Shu* and Gang Chen*
DOI: 10.2174/1567201813666160822104813
Erythropoietin Treatment in Patients with Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Research Article
Blockage of Central Sphingosine-1-phosphate Receptor does not Abolish the Protective Effect of FTY720 in Early Brain Injury after Experimental Subarachnoid Hemorrhage
, 14(6): 861 - 866Yu Hasegawa*, Ken Uekawa, Takayuki Kawano, Hidenori Suzuki and Shokei Kim-Mitsuyama
DOI: 10.2174/1567201813666160907094401
Blockage of Central Sphingosine-1-phosphate Receptor does not Abolish the Protective Effect of FTY720 in Early Brain Injury after Experimental Subarachnoid Hemorrhage
Research Article
Intranasal Delivery of Microspheres Loaded with 20 (R)-ginsenoside Rg3 Enhances Anti-Fatigue Effect in Mice
, 14(6): 867 - 874Wei Zhang, Xiaoyu Wang, Min Zhang, Min Xu, Wenyan Tang, Yi Zhang, Lei Lu, Jing Gao* and Shen Gao*
DOI: 10.2174/1567201814666161109121151
Intranasal Delivery of Microspheres Loaded with 20 (R)-ginsenoside Rg3 Enhances Anti-Fatigue Effect in Mice
Research Article
Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery
, 14(6): 875 - 886Doaa Nabih Maria, Sanjay R. Mishra, Lijia Wang, Abd-Elgawad Helmy Abd-Elgawad, Osama Abd-Elazeem Soliman, Marwa Salah El-Dahan and Monica M. Jablonski*
DOI: 10.2174/1567201813666160808111209
Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery
Research Article
Cell Line and Augument Cellular Uptake Study of Statistically Optimized Sustained Release Capecitabine Loaded Eudragit S100/PLGA(poly(lacticco- glycolic acid)) Nanoparticles for Colon Targeting
, 14(6): 887 - 899Sonia Pandey*, Sanganala Mattha Vijayendra Swamy, Udhshu Mansha Ubaid Ulla, Arti Gupta, Hetal Patel and Jitendra Singh Yadav
DOI: 10.2174/1567201813666160817150621
Cell Line and Augument Cellular Uptake Study of Statistically Optimized Sustained Release Capecitabine Loaded Eudragit S100/PLGA(poly(lacticco- glycolic acid)) Nanoparticles for Colon Targeting
  |
Editor-in-Chief
Xing-Jie Liang
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety
National Center for Nanoscience and Technology of China
Beijing
P.R.China
CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety
National Center for Nanoscience and Technology of China
Beijing
P.R.China
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Drug Delivery was launched in 2004. Dr. Xing-Jie Liang serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net